A-One Treatment Ltd is involved in the Research and Development (R&D) of a new Covid vaccine for new born children. There is expected to be a very large market for this vaccine in Australia and for other countries world-wide. Once developed it is expected to generate many millions of dollars in revenue for A-One Treatment Ltd. For this R&D it has incurred the following expenditure:

a) $100,000 for obtaining a general understanding of the Covid

b) $60,000 was spent on conducting various surveys related to the health of new born children

c) $200,000 was used for conducting various tests on the new vaccine

d) $500,000 for developing and testing a final product (Covid Vaccine)

Required:

For each of above expenditure determine clearly how each expenditure will be treated for accounting purposes.